Female sexual dysfunction (FSD) is currently categorized according to disorders of (i) desire, (ii) arousal, (iii) orgasm and (iv) sexual pain. The advancement of research defining the physiological, pathophysiological and psychological mechanisms of these disorders, and to develop treatments for FSD, has been hampered by the paucity of experimental paradigms and animal models. It may be that animal models of FSD are best suited to address arousal disorders that include persistent or routine inability to attain or maintain genital lubrication or engorgement. Although still limited in scope, experimental models of FSD have involved a range of in vitro to in vivo methodologies. Specifically, the in vitro and in situ models include vaginal or clitoral smooth muscle preparations, histological evaluation and vaginal blood flow assessments. Previously, in vivo studies of sexual responses focussed on behavioral paradigms involving lordotic posturing and receptivity, as well as indices of motivation using a dual chamber pacing method. Recently, a new model of female sexual arousal was developed using pharmacological CNS stimulation; responses that were found to be sensitive to cardiovascular status, aging and hormonal conditions. It is important that a wide variety of animal models continue to be developed to reflect the multifactorial basis of the condition.
Introduction
Although female sexual dysfunction (FSD) is not by itself a single disease, this term has been adopted to denote a range of medical problems that can include loss of libido, lack of desire for intimacy, inability to become appropriately aroused, a diminished sex drive as well as pain during sex.
1,2 Based on these signs and symptoms, FSD has been classified according to disorders of (i) desire, (ii) arousal, (iii) orgasm and (iv) sexual pain. Recently, it was reported that in the 18-59 y age group, 43% of women suffer from some type of sexual dysfunction. 1 Currently, as no female equivalent of Viagra s has been approved, it is not surprising that basic and clinical research labs and pharmaceutical companies are vigorously investigating potential solutions to FSD. The research in this area is directed at defining the physiological, pathophysiological and psychological mechanisms involved and developing suitable treatments. The success of this rapidly expanding field has been hampered by the paucity of experimental paradigms and animal models. Female sexual function in terms of physiological and psychological mechanisms appears to parallel male sexual function in many general respects (eg, clitoral physiology), 3 yet remains clearly distinct in terms of many of the specifics (eg, vasocongestive arousal) 4 and completely different in critical areas (eg, the importance of orgasm and pain). While the physiology of a female sexual response has not yet been fully elucidated, evidence to date suggests that nitric oxide (NO) and vasoactive intestinal polypeptide (VIP) play critical roles. NO, via the cyclic guanosine monophosphate pathway, has been shown to mediate nonadrenergic noncholinergic vasodilation of the clitoral cavernosal artery and helicine arteries, resulting in rapid inflow of blood causing an increase in intracavernosal pressure and clitoral engorgement. 5, 6 VIP release has been shown to increase vaginal blood flow and lubrication of the vaginal wall. 7, 8 The presence of neuropeptide Y, substance P and calcitonin G-related peptide also suggest that they are likely involved in the physiology of the clitoris.
The experience of previous research in male erectile function and dysfunction has shown that animal models are very useful in assessing basic physiology, pathophysiology and response to treatments. To date, no model(s) have emerged that meet the requirements of researchers interested in FSD as perhaps the nerve stimulation 10, 11 and central stimulation 12 models have for erectile dysfunction (ED).
Interestingly, assessment of the published literature reveals that although there has been a steady modest flow of experimental interest in female sexual and reproductive behaviors, the application of this knowledge to the development of novel treatment strategies has been even less emphasized. Currently, based on the prevalence of particular types of dysfunction, medical and clinical research focus has been on sexual arousal disorder. Arousal dysfunction may include a persistent or routine inability to attain or maintain genital lubrication or engorgement in response to sexual stimulation. Fortunately, it may be that animal models of FSD are best suited for this condition.
Clinical and basic research in male erectile dysfunction (MED) has been extensive. In basic research there has been a very important role for investigations involving animal models. Similarly, in the study of female sexual function, development of animal models will be integral in elucidating the complete spectrum of biochemical and physiological processes involved in female sexual response. There are currently a variety of models that are being developed that range from in vitro to in vivo and will be discussed in the present review. This range of experimental models is critical to understanding the pathways involved in the sexual response from the neural signals down to the chemical mediators resulting in the activation of specific aspects of female sexual response. Whole animal models examine both behavioral and genital responses as well as the changes in blood flow that facilitate these effects. However, in order to elucidate the mechanisms and second messenger systems responsible for arousal responses, isolated tissue strips and cells are used. These allow for an isolated and controlled environment that is not possible when evaluating the whole animal. Experimentation in a range of animals and in a range of models is important for determining the processes involved in female sexual response from the brain to the message transduction in the erectile tissues. The present review will discuss the current methods in vivo and in vitro and future areas of research interest.
In VivoFintroduction
Although there are exceptions, over the last few decades investigations of sexual function and dysfunction using conscious animals have been based on behavioral models and mating paradigms. In many of these studies, the changes assessed were behavioral responses that occurred in the presence of sexually experienced male rats. [13] [14] [15] For example, early work in the 1970s investigated the effects of brain lesions on the female lordotic posturing response. 15, 16 These types of studies laid the groundwork for the subsequent decades of research into the physiology surrounding this particular component of the sexual response although it is still far from clear what exactly remains in the human female sexual repertoire that might parallel lordosis.
Over the past 5-10 y, there has been a marked increase in research interest in the field of sexual medicine, paralleling the recognized importance of sexual dysfunction. Accordingly, in addition to behavioral models, a conscious model has been developed in which changes in genital morphology are induced via a centrally acting dopaminergic agent. 4 In addition, anaesthetized preparations have been established in which nerve stimulation produces changes in vaginal and clitoral blood flow 17, 18 Froughly paralleling the nerve stimulation experiments in ED research. While the conscious models allow for investigation of the overall changes in sexual function and behavior, the anesthetized models provide the means to further assess the physiology of the response at the tissue level.
Conscious animal studies
Attempts to develop in vivo animal models of the female sexual response have, for the most part, been limited to behavioral paradigms. CNS lesioning, microdialysis and microinjection studies combined with behavioral methods have provided important insight into the neurochemical pathways involved in the sexual response. 15, 16, [19] [20] [21] [22] Several measurements of sexual behaviors have been described including lordosis, hop, dart and kick responses, escapes from grasp, aggressive posture, fight attack, front attack, defensive/submissive posturing, rough grooming. These behaviors represent both procopulatory and anticopulatory responses 23 and the ratio between the two types has been used as an indicator of sexual interest.
Receptivity
A common approach in previous studies has been the assessment of female sexual receptivity based on a surrogate marker, lordotic posturing (in which the female rat demonstrates concave back flexion, lateral tail deviation and neck extension) 24 in
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relation to male copulatory contact. [24] [25] [26] The male rat mounts the female several times over a given time period. The ratio of lordotic responses to mounts is recorded; with changes in this ratio being indicative of increased or decreased female sexual responsiveness. 27 A problem with this approach is that in other studies these behavioral responses have persisted despite lesioning of the hypothalamus 15 Fa key central site for initiation of neurogenic sexual signaling. 28, 29 Furthermore, female behavioral/postural responses experimentally do not always include peripheral manifestations (ie increased blood flow to the genitalia) during sexual arousal. In fact, it may be that sexual dysfunction, occurring at the level of pudendal vasculature, may not even be detected using these behavioral paradigms alone.
Paced sexual behavior
An additional aspect to the behavioral receptivity model is the addition of an escape chamber, which allows female rats to pace their sexual activity. 13, 30 This method may indicate the level of interest or motivation to copulate. Specifically, in this situation the testing chamber is divided into a main chamber and a smaller escape chamber that is connected by holes through which only the female rat can pass. The latency between mounts and the frequency is assessed. It has been proposed that female rats that spend less time in the escape chamber are displaying a higher level of sexual desire. However, it is difficult to attribute such activity to sexual desire in that the motivation to copulate is different for humans and animals. That is, the purpose for rodent sexual activity appears to be focused on reproductive efficiency and behavioral changes may be based more on regulating the probability of pregnancy. Evidence in support of this demonstrated that when female rats were able to pace their mating, the female became pregnant (or pseudopregnant) after approximately half the number of attempts during nonpaced mating. 30 
Apomorphine-induced model of FSAD
A model of conscious female sexual responses has recently been established. 4 This model is based on the apomorphine (APO)-induced sexual response originally seen in male rats. APO is a dopamine receptor agonist (D 1 /D 2 ), and when administered at low doses acts as a central initiator of penile erections and yawns by binding somewhat selectively to the D 2 receptors of the paraventricular nucleus (PVN) of the hypothalamus. 12, 31 Previously, APO was shown to enhance lordosis behavior in female rats, 14, 25 and more recently the peripheral manifestation of this central action was found to involve vasculogenic engorgement of the genitalia, a key component of the sexual vasocongestive arousal response. 32, 33 APO induces behavioral responses in the both male and female rats including: a 'startle' response in which it appears that the rat becomes acutely aware of its surroundings, a movement involving the occurrence of concavity of the back leading to rearing and an erect posture on hind legs. Following these events, the rapid descent of the head into the genital area occurs immediately prior to genital arousal (genital vasocongestive arousal (GVA) in females, erection in males), and a final response that involves genital grooming. More importantly, APO administration induces a distinct change in the morphology of the external genitalia of the female rat. This genital response similar to the vasocongestive arousal (GVA) seen in males is characterized by significant genital engorgement (ie swelling of tissue surrounding the vagina as well as increased dimensions of the introitus that last 2-3 s). It is likely that this genital vasocongestion is associated with the increased blood flow to the genital area during sexual arousal, however, as of yet this has not been tested directly. As this model assesses a pharmacologically induced sexual response, it will be useful in future studies to facilitate the characterization of the mechanisms involved as well as the pathophysiological process that might interfere.
Anesthetized
Associated with female sexual dysfunction is a decreased blood flow to the genital wall as well as a decrease in lubricative secretions. Anesthetized rat and rabbit preparations have been established that allow for the assessment of both of these aspects using either Doppler flow 17, 34 or laser oximetry 18 to measure changes in blood flow resulting from peripheral nerve stimulation. Using this method, simultaneous measurements of blood flow, interstitial wall pressure/contraction and mean arterial pressure can be performed. 18 The impact of change in hormonal status, age and drug treatments can be assessed acutely using this technique to determine if the ability to increase blood flow to these areas has been enhanced or compromised. However, since this is an anesthetized preparation, the impact of the anaesthetic must be taken into consideration. For example, while the ICP/MAP ratio has become widely accepted, it is important to understand the impact of central nervous system depression on blood pressure. Further, while this approach allows for assessments of the physiologic ability of the rat to elicit components of the sexual response, it is based on an isolated and controlled environment that does Experimental models of FSD TM Hale et al not follow the natural central-peripheral pathway, that is, it emphasizes peripheral mechanisms.
In situ
Previously, an in situ perfusion preparation was designed for the assessment of changes in structurally based vascular resistance in the penis. 35 This work has aided in the elucidation of the location of the resistance vessels in this vascular bed and is a useful model for assessing changes in vascular resistance that would likely impact on erectile function. A similar model in female rats is currently under development for study of female structurally based vascular resistance. It is not known whether the same types of vascular remodeling can occur in the female pudendal vasculature, as has been previously described in the male. [36] [37] [38] In vitro studies
While whole animal models provide information into the physiology of the sexual response, it is critical to also examine isolated tissues and cells to determine the biochemical and signaling processes that are mediating these responses. Further, one can assess the impact that long-term treatment with drugs, or changes in hormonal status have on the function and morphology of tissues. These studies are critical in elucidating the mechanisms of action of drugs, as well as the etiologies of sexual dysfunctions that have a pathophysiological basis.
Histological assessments
Histological examination of genital tissues has provided insight into the types of changes that may be causally linked to sexual dysfunction. 34, 39 Specifically, the hormonal requirements for tissue integrity and growth of vaginal and clitoral tissues have been studied. For example, estrogen replacement following oophorectomy appeared to decrease the levels of clitoral collagen fiber content 39 which may be associated with the impaired vasocongestion. Thus, histological examination of these tissues may help ascertain the progressive changes in female sexual function and its correlation with fibrosis. In addition, use of histology has yielded information with regards to the interaction between estrogen and the nitric oxide system. 40 Finally, as the mechanisms of control become established, histochemical localization will remain an important methodological approach used to determine the tissue distribution of chemical mediators, receptors and other molecules involved in signal transduction.
Isolated tissues and cells
Characterization of the biochemical processes and contractile properties of tissues involved in the sexual response has been aided by the use of cell culture and organ baths. Second messenger systems involved in the contraction of both vaginal and clitoral 41, 42 tissues have been assessed using in vitro tissue baths. Isolated strips of contractile tissue allow for the assessment of the responsiveness to chemical mediators and downstream messengers involved in the dilation and contraction without compensatory mechanisms that are present in the whole animal. These studies have provided a greater understanding of the chemical messengers responsible for dilation and contraction of this smooth muscle. Similarly, cell culture allows for further controlled conditions to examine the effects at the cellular level. 43 A disadvantage of these methods is that they do not provide a means of elucidating the integrative mechanisms occurring in the whole animal according to physiological importance but rather assess that a response is possible. For example, during the course of the experiment, tissues are not exposed to the same local and hormonal factors as would be present in vivo. As would be expected using a reductionist approach, therefore, the knowledge gained from in vitro experiments must eventually be validated using an in vivo model of sexual function or arousal.
Conclusions
The field of female sexual dysfunction is still in the early stages of research, and as a result there are many methodologies currently being expanded and developed. Further, it is important for findings to be validated in a range of models to ensure that the results are not dependent upon the conditions of a given experiment. Advancement of basic science research into the study of the etiology and mechanisms of female sexual dysfunction and the development of drug therapies are critical to effective management of this common condition.
